United States · FDA National Drug Code directory
neratinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46014-2400_4611a03e-3a5e-f1b5-e063-6294a90ad349
- Product NDC
- 46014-2400
- Form
- TABLET
- Composition / generic term
- neratinib
- Labeler
- Excella GmbH & Co. KG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20170717
- Source listing expiry
- 20261231
Source-listed ingredients
- NERATINIB MALEATE ANHYDROUS — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 133 TABLET in 1 BOTTLE (46014-2400-3) · 46014-2400-3
- 180 TABLET in 1 BOTTLE (46014-2400-8) · 46014-2400-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →